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What's New:
Compared to researcher affiliation and identity linkage of a child to a blood spot, consent protocol emerged as the strongest factor impacting Indiana parents' attitudes about using dried blood spots for research. This has implications for biospecimen use policy.
INTRODUCTION
Beginning in the 1960s, routine newborn screening began in the U.S. 1, 2 Since 1965, when it first started screening for phenylketonuria (PKU), the Indiana State Department of Health has collected newborn blood spots and now tests them for nearly four dozen conditions 3, 4 . Blood spots are collected for each child, and the residual dried blood spots (DBS) are stored for use in the event that positive findings must be confirmed or that screening must be repeated 5 . Residual DBS are stored indefinitely in Indiana and may be used for quality assurance after screening, but
are not released for research purposes 6 .
DBS are potentially useful in studies of conditions believed to be genetic or acquired in utero, studies of in utero environmental toxin exposure, and other research on biological conditions [7] [8] [9] [10] [11] . In Indiana, for example, given the state's strong electronic medical records systems, e.g., the Indiana Network for Patient Care 12 , DBS of Indiana-born children could be linked with their electronic medical records to identify early markers of conditions not currently screened for at birth. Moreover, using DBS is feasible and potentially cost-effective compared to collecting fresh blood specimens 10 .
Many states in the U.S. do not explicitly regulate the use of DBS for research purposes, and state policies surrounding the retention and use of DBS vary greatly 13 . Litigation focusing on DBS research use in the U.S. has varied in outcome. For example, Texas now has an opt-in policy where parents can both disallow their child's DBS for use in research and insist that the specimens be destroyed (specifically pertaining to spots collected on or after June 1, 2012) 14, 15 .
Researchers have long investigated attitudes towards children's participation in a variety of research [16] [17] [18] , and, more specifically, the use of pediatric biospecimens in research 19, 20 . Other work has focused on attitudes towards using DBS in research [21] [22] [23] [24] [25] . Consistently-emerging concerns of respondents in previous research involving use of biomaterial include:
anonymity/identifiability of the person whose material it is; the researcher using the biospecimen; and whether and how frequently parent consent is sought, among other factors [21] [22] [23] [24] [25] .
Policymakers have expressed a need for information concerning parental attitudes surrounding the research use of DBS in order to formulate acceptable policies governing their use 26 . However, little is known about the relative weight that parents place on the factors affecting their attitudes. Here we address the relative importance of three key factors in driving parental attitudes, providing needed information for the development of state policy and institutional research practices.
Our hypothesis was that parents differently weight concerns about the use of their children's DBS. These concerns included: 1) whether consent is sought, 2) the affiliation of the researcher using the DBS, and 3) whether their children's identity is linked to the DBS. We chose these factors based on existing work [21] [22] [23] [24] [25] and hypothesized that the issue of consent was likely to emerge as the most significant concern.
METHODS

Survey Development
We employed conjoint analysis, a multivariate technique commonly used in marketing research and increasingly in health-related research, including work on attitudes about biobanking 27 . Conjoint analysis is often used to determine respondent preferences when multiple features or attributes impact a decision [28] [29] [30] . We chose a full-profile, ratings-based design. The survey items were generated using SPSS 17® 31 .
A full-factorial, within-subjects, repeated measures design produces 12 scenarios (3 levels of consent X 2 levels of identity linkage X 2 levels of who is conducting research).
However, we were interested in conceptualizing respondents' ratings as relative preferences, and the conjoint analysis approach aligns with this objective. This approach produced eight experimental survey items. We then strengthened the design by including four additional holdout items. Participants' responses to these holdout items are used as a conjoint analysis model validation check. This resulted in a total of 12 orthogonal survey items. We included a 13 th duplicate item as an index of intra-respondent reliability as has been done by other investigators 32 .
The paper-based survey's 13 hypothetical scenarios followed the same pattern of information delivery: 1) who (academicians or a pharmaceutical company) would be conducting the research using the DBS, 2) whether the child's identity would be linked to his/her DBS, and 3) whether the parent's consent would be sought once for all research (one-time, blanket consent), every time the child's DBS would be used for research, or not at all. Respondents were asked to rate each of the scenarios via an 11-point semantic differential scale, anchored at "Completely Unacceptable" (0) and "Completely Acceptable" (100). There were five different survey versions with the order of the 13 scenarios randomized to minimize order-effects. Figure   1 reflects survey item wording.
[ Figure 1 The RA explained the study and asked the respondents to complete a few questions, including ages and sexes of children, whether they recalled the referent child receiving a heelstick before leaving the hospital when the baby was born, and whether they had heard of newborn screening. The RA then provided respondents with general information about newborn screening (the "heelstick") in Indiana, as well as the storage of the DBS. The RA then informed participants they would rate the acceptability of 13 unique scenarios, each with different information that described fictional ("what-if") research situations that were not actually taking place, followed by some general demographic questions. The RA reiterated that the survey was anonymous and that the scenarios depicted in the survey were not real.
Respondents completed surveys in 12-15 minutes, primarily while in clinic waiting rooms before appointments. Occasionally, respondents and their children were called back for their appointments before they completed their surveys. When this occurred, respondents were instructed to return the survey to the RA when their appointments finished. Respondents received a $5 gift card for completing the survey.
An RA scanned the completed surveys. Optical character recognition software identified responses, recorded them to a database, and the RA reviewed each survey's scanned responses to ensure data accuracy.
Data Analysis
Survey responses were analyzed using conjoint analysis. Conjoint analysis produces importance scores, denoting which factors most strongly impact preferences/attitudes, and partworth utility values, denoting respondents' preferences (here, preferences for what are acceptable research situations). Conjoint analysis also produces Pearson's R and Kendall's tau. The
Pearson's R coefficient is an indicator of fit between the conjoint analysis model (i.e., predicted responses) and respondents' observed (i.e., actual) responses to the eight experimental survey items. The Kendall's tau coefficient for the four holdout items was generated; this is the coefficient denoting how well the observed (i.e., actual) responses correlate with the predicted responses as produced by the holdout items. This Kendall's tau for holdouts serves as a model validation index. We also report the correlation for the redundant survey items as a reliability check. All analyses were conducted using SPSS 17® 31 .
First, we report overall importance scores for the factors, which denote the impact of each factor (researcher affiliation, identity linkage, and consent) upon acceptability ratings.
Specifically, these importance scores denote the percentage of respondents' preferences that are explained by the factors we included in our study, and, therefore, sum to 100 (give or take due to rounding).
Next we examined the part-worth utility values, which sum to zero for each factor. While importance scores indicate how strongly a factor drives one's preferences, part-worth utilities convey the preferences associated for the specific attribute levels within those factors (e.g.,
whether the respondent exhibited a preference for university researchers versus drug company researchers using the DBS).
RESULTS
Of the 593 potential respondents approached, 521 (88%) agreed to participate. The 72 (12% of 593) non-participants were ineligible, uninterested, or indicated they did not have time.
Of the 521 who agreed to participate, 506 (97%) respondents completed the survey, and 15 (3%)
either did not complete it or returned a survey to the RA with missing pages.
Respondents ranged in age from 18-63 with a mean age of 32 years. The referent child about whom the survey was completed ranged in age from newborn to 17 years of age with a mean age of 5.7 years. Referent children were predominantly male (51%). Respondents were predominantly Black or African American, not Hispanic or Latino, female, and were mother to the referent child. The referent child was most likely a Medicaid recipient. Other descriptive demographic data, including political affiliation, income, and religiosity are noted in Table 1 .
[ Table 1 
about here.]
Over three-quarters of respondents (75%) indicated that they recalled their children receiving a heelstick when they were born. However, fewer respondents indicated that they had heard of newborn screening (60%).
We first calculated overall acceptability ratings for each of the 13 scenarios. Table 2 presents the scenarios and their overall acceptability ratings. In the scenario rated as least acceptable the researcher affiliation was a drug company, the child's identity was linked to the DBS, and consent was not sought (M = 28.6; SD = 36.4). In the scenario rated as most acceptable, the researcher affiliation was a university, the child's identity was not linked to the DBS, and consent was sought for each and every use of the DBS (M = 78; SD = 29.7). Of note, just over 2% (12/506) of respondents found research use of DBS "completely unacceptable" across all scenarios, and nearly 9% (45/506) found it "completely acceptable" across all scenarios. We also conducted an Analysis of Variance (ANOVA) to determine whether demographic characteristics impacted acceptability ratings. We did not find any statistically significant effects of respondent race, respondent ethnicity, child and respondent sex, child and respondent age, or parents' awareness of newborn screening (all Fs<3.0, all ps>.09, ns).
[ failed to respond to all scenarios. Conjoint analysis requires that all survey items have responses and that there be some variability among the responses (to denote preferences). Table 3 contains the fit indices generated by the conjoint analysis. The model showed strong fit with a high Pearson's R by indicating that the predictive conjoint analysis model strongly fits the responses to the eight experimental survey items. The Kendall's tau for holdouts also suggests that the fit between the actual ratings provided by respondents on the eight experimental survey items and the predicted ratings generated by the four holdout model validation items is very strong. The duplicated survey item showed a strong correlation of .87, indicating high response reliability.
[ Table 3 about here.] Figure 2 presents the importance scores. Consent was the most important factor in respondents' ratings of acceptability of the scenarios (average importance score of 64.9). This was followed by identity linkage (average importance score of 19.4), and lastly, the affiliation of the researcher using the DBS (average importance score of 14.6).
[ 
DISCUSSION
This predominantly minority, low-income study sample overwhelmingly conveyed that parents do not find acceptable (i.e., do not prefer) situations in which their consent would not be sought in order to use their children's DBS in research. They preferred that their consent be sought for every use of the child's DBS. Though not as strong an influence on attitudes, respondents preferred that the child's identity not be linked to the DBS and the research be conducted by university researchers. Most respondents report that they recall their children 
Limitations and Future Directions
Although this study contributes to the understanding of parents' preferences concerning the research use of their children's biomaterial, several limitations should be noted. First, we only studied three factors that have emerged as important in previous literature (consent, identity linkage, and researcher affiliation), though many others may impact parents' attitudes surrounding the research use of DBS 21-25 .
Another limitation is that respondents rated the acceptability of hypothetical scenarios.
'Real' requests to use their children's DBS could produce different results. It is also possible that respondents, especially when completing the survey in a busy, clinic setting, may not have fully understood the information conveyed in the 13 hypothetical scenarios. No respondents in our study sample, nor any of the 15 respondents to the pilot test, indicated that they had difficulty understanding the information being conveyed in the scenarios or the general information presented by the RA regarding newborn screening or blood spot storage. We used the terms "newborn screening" and "heelstick" to gauge participants' awareness and recall of newborn Future directions could build upon this work by eliciting parental preferences for the timing and structure of the consent process. For example, do they prefer an "opt-in" or "opt-out" structure? Do they prefer to be asked at the time of the screening or prior to the baby's arrival?
Moreover, future studies could focus on the situations in which identity linkage or consent waivers might be permissible, as well as parental preferences for being informed of study results involving their child's DBS.
CONCLUSIONS
Policymakers, those leading biobanking initiatives, and researchers using minors' biomaterial in their work might benefit from taking parents' preferences into consideration when developing protocols for the use of children's biomaterial, especially consent policies. Though logistic problems with seeking consent for DBS research use might seem overwhelming, such consent is not necessarily unattainable 35 . Public preferences are critically important for policymakers to keep in mind when developing governance policies; it is also imperative that policymakers understand that preferences can vary depending on the parameters of DBS use. For example, if the DBS are being used in research identifying treatable illnesses, perhaps parents would want their children's identities linked to their specimens so that they could be notified.
Further, democratic deliberation approaches that have been employed in biobankingrelated research 36,37 and involve intensive education efforts and ongoing discourse between citizens and those responsible for policymaking, might render different sentiments from parents regarding use of their children's biomaterial. However, many individuals from whom consent would be sought for DBS use would not likely be able to participate in long-term, ongoing, intensive education and dialogue about biomaterial use. This study's objective was to measure attitudes from these individuals not undergoing a democratic deliberation process.
Lastly, states that have already implemented governance policies on this topic, especially if it does not involve seeking consent from parents for use of DBS, might benefit from a reevaluation of such policy. Table 2 for listing of variable combinations reflected in each scenario). 
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